CYO HOLDINGS PTE. LTD.
UEN: 201308776C
CYO HOLDINGS PTE. LTD.(201308776C) is a Singapore business with registered business address at 9 BATTERY ROAD, 15-1, MYP CENTRE, Singapore 49910. They specialise in the area of OTHER HOLDING COMPANIES and OFFICE ADMINISTRATIVE SERVICES ON A FEE OR CONTRACT BASIS (EG BILLING AND RECORD KEEPING).
| Company Name | CYO HOLDINGS PTE. LTD. |
| Unique Entity Number | 201308776C |
| Entity Type | Local Company |
| Entity Status | Live Company |
| Incorporate Day | 03 April 2013 |
| Address |
9 BATTERY ROAD #15-1 MYP CENTRE Singapore 49910 |
| Products / Services |
OTHER HOLDING COMPANIES OFFICE ADMINISTRATIVE SERVICES ON A FEE OR CONTRACT BASIS (EG BILLING AND RECORD KEEPING) |
| Number of Officers | 4 |
| Paid Up Capital | SGD 550000 |
Breaking! Business News
OMERS Infrastructure Agrees to Purchase 19.4% Stake in Azure PowerOMERS Infrastructure Agrees to Purchase 19.4% Stake in Azure PowerTransaction expands Canadian pensi...
Read More
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages 360 DigiTech, Inc. Investors with Losses Over $100K to Secure Counsel Before Important September 13 Deadline in Securities Class Action – QFINROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages 360 DigiTech, Inc. Investors with Losses Over ...
Read More
RISULTATI DEL SECONDO TRIMESTRE 2021RISULTATI DEL SECONDO TRIMESTRE 2021GlobeNewswireJuly 30, 2021The following is an extract from the ...
Read More
India’s United Breweries becomes part of the HEINEKEN groupIndia’s United Breweries becomes part of the HEINEKEN groupGlobeNewswireJuly 30, 2021HEINEKEN obta...
Read More
AKWEL: TURNOVER INCREASES 26% IN THE FIRST HALF OF 2021AKWEL: TURNOVER INCREASES 26% IN THE FIRST HALF OF 2021GlobeNewswireJuly 30, 2021 Thu...
Read More
Responsible babies lifestyle brand, Malabar Baby, has launched a new collection of wearable blankets...
Read More
Sydney sportswear company Champion System Australia has updated its offerings with Glide fabric. Cus...
Read More
Junshi Biosciences Announces Acceptance by NMPA of Supplemental New Drug Application for Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell CarcinomaJunshi Biosciences Announces Acceptance by NMPA of Supplemental New Drug Application for Toripalimab...
Read More